At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- The Microbiome Is Not a Bar Code
- Not All False-Positive Stool DNA Tests Should be Dismissed (GI & Endoscopy News)
- Physicians & Private Equity: What to Examine Before You Engage (Physician’s Weekly)
- Is professional coaching worth it? A practical guide for early-career gastroenterologists (GI & Hepatology News)
- Albany Gastroenterology Consultants Data Breach Settlement (Claims Depot)
- Water Exchange Colonoscopy Boosts Adenoma Detection in Real-World Practice (Medscape)
- Hinge Health to acquire Cylinder Health in a $105M deal to expand into gastrointestinal care (Fierce Healthcare)
- The colonoscopy reimbursement math is not adding up (Becker’s Healthcare)
